Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Amicus Therapeutics, Inc. (FOLD) a Joel Greenblatt Stock?
High-quality business at a cheap price - strong Magic Formula fit.
69/100
CMixed signals
1/5 criteria passed
+2 sector-quality lift. Top-quintile within its sector on 1 of 5 quality metrics. Raw pillar score 67 → lifted to 69 before grade derivation.
Capped from B to C. EV/EBIT over 30 means EBIT yield below ~3% - too expensive to qualify for Magic Formula What are deal-breaker caps?
Joel Greenblatt's Criteria, Applied to FOLD
EBIT/EV yield ≥ 10%
key0.7%
ROIC ≥ 25%
key-
EV/EBIT ≤ 12
139.7x
Gross margin ≥ 30%
87.9%
How FOLD Scores on Other Strategies
Live Financial Snapshot
Market cap
-
P/E (TTM)
-
ROIC (TTM)
-
Gross margin
-
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is FOLD's Joel Greenblatt fit score?
FOLD scores 69/100 on our Joel Greenblatt fit engine - grade C. High-quality business at a cheap price - strong Magic Formula fit.
Does Joel Greenblatt actually own FOLD?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends FOLD.
How often is this score updated?
FOLD's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends FOLD.